These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22798523)

  • 21. Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure.
    Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM; Kosoglou T
    Clin Sci (Lond); 1996 Sep; 91(3):283-91. PubMed ID: 8869410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
    Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
    Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urocortin 3: haemodynamic, hormonal, and renal effects in experimental heart failure.
    Rademaker MT; Cameron VA; Charles CJ; Richards AM
    Eur Heart J; 2006 Sep; 27(17):2088-98. PubMed ID: 16825287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
    Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
    Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiorenal actions of TRV120027, a novel ß-arrestin-biased ligand at the angiotensin II type I receptor, in healthy and heart failure canines: a novel therapeutic strategy for acute heart failure.
    Boerrigter G; Lark MW; Whalen EJ; Soergel DG; Violin JD; Burnett JC
    Circ Heart Fail; 2011 Nov; 4(6):770-8. PubMed ID: 21835984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
    Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
    Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic, hormonal, and renal effects of adrenomedullin in conscious sheep.
    Charles CJ; Rademaker MT; Richards AM; Cooper GJ; Coy DH; Jing NY; Nicholls MG
    Am J Physiol; 1997 Jun; 272(6 Pt 2):R2040-7. PubMed ID: 9227626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic and hormonal effects of renin inhibition in ovine heart failure.
    Fitzpatrick MA; Rademaker MT; Frampton CM; Charles CJ; Yandle TG; Espiner EA; Ikram H
    Am J Physiol; 1990 Jun; 258(6 Pt 2):H1625-31. PubMed ID: 2193544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic therapy with an ET(A/B) receptor antagonist in conscious dogs during progression of congestive heart failure. Intracellular Ca(2+) regulation and nitric oxide mediated coronary relaxation.
    Shen YT; Buie PS; Lynch JJ; Krause SM; Ma XL
    Cardiovasc Res; 2000 Nov; 48(2):332-45. PubMed ID: 11054479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological actions and pharmacokinetics of C-type natriuretic peptide in conscious sheep.
    Charles CJ; Espiner EA; Richards AM; Nicholls MG; Yandle TG
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R201-7. PubMed ID: 7840321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardio-renal-endocrine dynamics during stepwise infusion of physiologic and pharmacologic concentrations of atrial natriuretic factor in the dog.
    Zimmerman RS; Schirger JA; Edwards BS; Schwab TR; Heublein DM; Burnett JC
    Circ Res; 1987 Jul; 61(1):63-9. PubMed ID: 2955951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (Pro)renin Receptor Blockade Ameliorates Heart Failure Caused by Chronic Kidney Disease.
    Yoshida A; Kanamori H; Naruse G; Minatoguchi S; Iwasa M; Yamada Y; Mikami A; Kawasaki M; Nishigaki K; Minatoguchi S
    J Card Fail; 2019 Apr; 25(4):286-300. PubMed ID: 30769036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic effects of angiotensin and renin inhibition in dogs with acute left ventricular failure.
    Sweet CS; Ludden CT; Frederick CM; Ribeiro LG
    Am J Med; 1984 Aug; 77(2A):7-12. PubMed ID: 6089558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Four-day urocortin-I administration has sustained beneficial haemodynamic, hormonal, and renal effects in experimental heart failure.
    Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Lainchbury JG; Richards AM
    Eur Heart J; 2005 Oct; 26(19):2055-62. PubMed ID: 15961410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (Pro)renin receptor in skeletal muscle is involved in the development of insulin resistance associated with postinfarct heart failure in mice.
    Fukushima A; Kinugawa S; Takada S; Matsushima S; Sobirin MA; Ono T; Takahashi M; Suga T; Homma T; Masaki Y; Furihata T; Kadoguchi T; Yokota T; Okita K; Tsutsui H
    Am J Physiol Endocrinol Metab; 2014 Sep; 307(6):E503-14. PubMed ID: 25074986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of sodium nitrite on renal function and sodium and water excretion and brachial and central blood pressure in healthy subjects: a dose-response study.
    Rosenbaek JB; Al Therwani S; Jensen JM; Mose FH; Wandall-Frostholm C; Pedersen EB; Bech JN
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F378-F387. PubMed ID: 28490529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure.
    Boerrigter G; Costello-Boerrigter LC; Cataliotti A; Tsuruda T; Harty GJ; Lapp H; Stasch JP; Burnett JC
    Circulation; 2003 Feb; 107(5):686-9. PubMed ID: 12578869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure.
    Münzel T; Kurz S; Holtz J; Busse R; Steinhauer H; Just H; Drexler H
    Circulation; 1992 Oct; 86(4):1089-98. PubMed ID: 1394917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.